EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Antibody glyco-optimization and site-specific conjugation enhance the immune-stimulating activity of antibody–TLR ligand conjugates

Xianyang Wang, Yaoxian Lou, Helena Yun, Margaryta Gomozkova, Guangming Li, Lishan Su, Lai-Xi Wang

Journal of Biological Chemistry · 2026-08 · 302 (8) · 113269

DOI: 10.1016/j.jbc.2026.113269 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2026-08. Verfasst von Xianyang Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Biochemistry, University of Maryland, College Park, Maryland, USA. Hauptthemen laut MEDLINE: Immunoconjugates, Trastuzumab, Toll-Like Receptors. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NCI NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunoconjugatesTrastuzumabToll-Like ReceptorsHumansLigandsGlycosylationToll-Like Receptor AgonistsAnimals

Stichwörter der Autor:innen

Fc glyco-optimizationantibody glycoengineeringimmune activationimmune-stimulating antibody conjugates (ISACs)site-specific bioconjugation

Substanzen

LigandsImmunoconjugatesToll-Like Receptor AgonistsTrastuzumabToll-Like Receptors

Autor:innen und Institutionen

  • Department of Chemistry and Biochemistry, University of Maryland, College Park, Maryland, USA.
  • Division of Virology, Pathogenesis and Cancer, Department of Pharmacology and Physiology, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Department of Chemistry and Biochemistry, University of Maryland, College Park, Maryland, USA. Electronic address: wang518@umd.edu.

Förderung

  • NIAID NIH HHS
  • NCI NIH HHS
  • National Institutes of Health

Zitieren

APA

Wang, X., Lou, Y., Yun, H., Gomozkova, M., Li, G., Su, L., & Wang, L. X. (2026). Antibody glyco-optimization and site-specific conjugation enhance the immune-stimulating activity of antibody–TLR ligand conjugates. Journal of Biological Chemistry, 302(8), 113269. https://doi.org/10.1016/j.jbc.2026.113269

Vancouver

Wang X, Lou Y, Yun H, Gomozkova M, Li G, Su L, et al. Antibody glyco-optimization and site-specific conjugation enhance the immune-stimulating activity of antibody–TLR ligand conjugates. Journal of Biological Chemistry. 2026;302(8):113269. doi:10.1016/j.jbc.2026.113269

BibTeX
@article{Wang2026,
  author = {Wang, Xianyang and Lou, Yaoxian and Yun, Helena and Gomozkova, Margaryta and Li, Guangming and Su, Lishan and Wang, Lai-Xi},
  title = {Antibody glyco-optimization and site-specific conjugation enhance the immune-stimulating activity of antibody–TLR ligand conjugates},
  journal = {Journal of Biological Chemistry},
  year = {2026},
  volume = {302},
  number = {8},
  pages = {113269},
  doi = {10.1016/j.jbc.2026.113269}
}
Kostenlos starten →